Biotechnology-3.1

Executive Search for Biotech Companies

Summary

Biotechnology is one of the most dynamic areas of the life sciences industry. Scientific excellence, regulatory requirements, capital market pressure and societal impact come together directly in this field. Whether cell and gene therapies, RNA-based platforms, personalised medicine or AI-enabled drug discovery – biotech companies need leaders who can successfully drive innovation from a strategic, regulatory and commercial perspective.

 

Switzerland is one of Europe’s leading biotech locations. Basel, Zurich/Zug/Schlieren, Lausanne, Geneva and the Health Valley of Western Switzerland bring together pharmaceutical companies, specialised biotech firms, universities, hospitals, CDMOs, investors and regulatory expertise within a highly concentrated ecosystem. This density creates opportunities, but also intensifies the competition for outstanding leadership talent.

 

Why Wirz & Partners?

Wirz & Partners supports biotech companies, life sciences investors and growth-oriented organisations in filling key positions at board, C-level and senior management level. We identify leaders who understand biotechnology from a technical perspective and can guide companies through critical development phases – from proof of concept, clinical trials and regulatory strategy to financing, partnerships, market entry or exit.

Challenges in biotech leadership recruitment

 

Biotech companies face a distinct leadership challenge: organisations are often highly specialised, internationally oriented and capital-intensive – while frequently still being in an early development or scaling phase. Leaders therefore need more than outstanding technical expertise. They must be able to navigate ambiguity, convince investors, build teams and steer regulatory milestones with precision.

 

Typical challenges in the biotech environment include:

  • Scientific excellence must be translated into entrepreneurial strategy – research only creates value when pipeline, IP, financing and clinical development are clearly prioritised.
  • Capital is a strategic bottleneck – CEOs and CFOs must credibly manage financing rounds, investor relations, partnerships and potential exit scenarios.
  • Regulation and clinical development determine speed – CMOs, Heads of Clinical Development and Regulatory Affairs leaders must integrate trial design, authority interaction and data quality from an early stage.
  • Scaling changes leadership requirements – the transition from a research organisation to a clinical or commercial company requires new structures, processes and leadership capabilities.
  • Talent is scarce – experienced leaders with biotech, pharma, CDMO, MedTech and capital market experience are in high demand internationally.

Wirz & Partners identifies these requirements early and develops search profiles that go beyond traditional job descriptions. The decisive factor is not only whether someone has previously held a specific function, but whether the person fits the company’s development stage, financing situation, culture and strategic ambition. 

 

What defines the Swiss biotech market today

The Swiss biotech sector continues to demonstrate strong resilience despite volatile capital markets. The market is shaped by high investments in research and development, financing from private equity, venture capital and institutional investors, international alliances and proximity to leading pharmaceutical and research institutions. At the same time, expectations placed on leadership teams are rising: investors demand clear milestones, regulators expect robust data, partners assess strategic fit and talent looks for organisations with a credible mission.

 

Switzerland benefits from several structural strengths:

Basel Area

 

Basel is one of the world’s most important pharma and biotech locations. Roche, Novartis, research institutions, incubators and specialised service providers create an environment where scientific innovation, clinical development and global scaling are closely connected.

Health Valley and Western Switzerland

 

Lausanne, Geneva, Bern and Valais form a dense life sciences ecosystem with EPFL, CHUV, Campus Biotech, Biopôle Lausanne, BioArk and other innovation platforms. The region is particularly strong in translational research, clinical collaborations, digital health, diagnostics and MedTech-related biotechnology.

Greater Zurich, Zug and Schlieren

 

Zurich and Zug combine international headquarters, investors, universities, hospitals and biotech start-ups. ETH Zurich, University Hospital Zurich, Bio-Technopark Schlieren and global life sciences companies such as Biogen, Amgen, BMS, AbbVie, Gilead and Alnylam shape the region’s ecosystem.

International alliances

 

Biotech is global by nature. Swiss companies rarely develop products, platforms and therapies in isolation, but in partnership with pharmaceutical companies, universities, hospitals, CDMOs, investors and regulatory stakeholders. Leaders therefore need to combine scientific depth with the ability to collaborate internationally.

Typical leadership requirements in biotech

 

Our experience shows that leadership requirements in biotech vary significantly depending on the company’s development stage. A preclinical platform company requires different profiles than a clinical Phase II company, a CDMO-related growth business or a listed biotech company with an international partnering focus.

 

Typical responsibilities and requirements include:

  • CEO with biotech experience, financing strength and the ability to align scientific vision, board expectations and investor logic
  • CSO with an excellent scientific reputation, IP understanding and the ability to translate scientific platforms into marketable development programmes
  • CMO or Head of Clinical Development with experience in clinical trials, indication strategy and regulatory dialogue
  • CFO with capital markets, fundraising, controlling and investor relations experience in life sciences
  • CBO or Head of Business Development with strong deal-making capabilities, partnering experience and an understanding of pharma portfolio logic

With our executive search approach, we identify leaders who not only master these responsibilities functionally, but also fit the company’s stage, culture and strategic direction.

 

Executive Search as a strategic lever for biotech companies

In biotechnology, every key appointment is a strategic decision. A new CEO can change a company’s financing capability. An experienced CMO can sharpen the clinical development strategy. A strong CBO can open access to pharma partnerships. An independent board member can strengthen governance, investor confidence and scientific prioritisation.

 

Especially in early-stage and high-growth biotech companies, the talent market is often not transparent. The best leaders are rarely actively looking. They need to be identified selectively, approached discreetly and engaged with a compelling strategic narrative.

 

Wirz & Partners acts as a sparring partner for founders, boards, investors and executive teams. We understand the language of science, capital markets, regulation and corporate leadership – and translate this into a search profile that reflects the company’s true success factors.

 

Our goal is not simply to fill an open position quickly. Our goal is to find the right leader for the next stage of development.

 

Why Wirz & Partners?

  • Industry-specific know-how – deep understanding of life sciences, biotech, pharma, MedTech, digital health and regulated innovation environments
  • Access to leadership talent – discreet direct approach to candidates who are not actively searching
  • Understanding of development stages – from seed- and venture-backed biotech companies to listed or pharma-related organisations
  • Board and C-level experience – filling board, CEO, CFO, CMO, CSO, COO, CBO and other critical leadership roles
  • Strategic search process – clear market analysis, precise approach, structured evaluation and strong focus on cultural fit
  • International perspective – access to talent across Switzerland, DACH, Europe and global life sciences markets
  • Discretion and confidentiality – careful handling of strategic search mandates, succession topics and confidential growth phases

We bring together scientific excellence, regulatory understanding and leadership perspective – with precision, discretion and a focus on long-term impact.

 

Conclusion

The Swiss biotech industry stands for innovation, international connectivity and scientific substance. At the same time, the sector requires leaders who can translate research into strategy, strategy into financing and financing into clinical and commercial impact.
 
Wirz & Partners helps biotech companies find exactly these leaders – for boards, executive teams and critical key positions across the entire value chain.
 

 

Ready to appoint the right leader for your next key role?

Whether CEO, CMO, CSO, CFO, CBO, Head of Clinical Development, Head of Regulatory Affairs or board member – we find leaders who can guide your biotech company into its next stage of development.